glp-1 receptor agonists should be avoided in patients with A System-Based Review on Effects of Glucagon-Like Peptide-1 Agonists: Benefits vs Risks GLP-1 Receptor Agonists as Treatments

The researchers found comparable levels of carnitine absorption and metabolism between men and women, suggesting that gender should not affect dosage

But the current crop of synthetic peptides comes with the promise of astronomical profit

transient impairment of glucose tolerance is possible, particularly in individuals with pre-existing insulin resistance Injection site reactions: Mild and typically localised Contraindications include active malignancy (GH-IGF-1 signalling can promote tumour growth), pituitary-dependent conditions, pregnancy, and active diabetic retinopathy

In a recent study, Sasuclark et al

RiedijkMAvan GoudoeverJB

Psychiatric comorbidity in diabetes type 1: a cross-sectional observational study